Skip to main content

Peer Review reports

From: A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)

Original Submission
27 Jun 2023 Submitted Original manuscript
5 Sep 2023 Reviewed Reviewer Report - Maria Antonietta Barbieri
15 Sep 2023 Reviewed Reviewer Report
28 Sep 2023 Author responded Author comments - Ming-hui Sun
Resubmission - Version 2
28 Sep 2023 Submitted Manuscript version 2
4 Oct 2023 Reviewed Reviewer Report - Maria Antonietta Barbieri
5 Oct 2023 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
31 Oct 2023 Editorially accepted
13 Nov 2023 Article published 10.1186/s40360-023-00702-w

You can find further information about peer review here.

Back to article page